Rocket Pharmaceuticals, Inc.RCKTNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank54
3Y CAGR-0.3%
5Y CAGR-24.2%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-0.3%/yr
vs -22.3%/yr prior
5Y CAGR
-24.2%/yr
Recent acceleration
Acceleration
+22.0pp
Accelerating
Percentile
P54
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.89M | +0.3% |
| 2024 | $1.89M | +0.6% |
| 2023 | $1.88M | -1.8% |
| 2022 | $1.91M | -67.6% |
| 2021 | $5.89M | -22.0% |
| 2020 | $7.55M | +57.8% |
| 2019 | $4.78M | -8.7% |
| 2018 | $5.24M | +46.4% |
| 2017 | $3.58M | +152.4% |
| 2016 | $1.42M | - |